Excellergy
Palo Alto
About Excellergy
Excellergy develops immunology-based therapies focused on treating allergic diseases through novel biologic drug candidates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $70.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2025)
- Website: excellergy.com
- Phone: 1 4089155571
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/excellergy-125111 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.